News
The research announcement comes after Colossal Bioscience similarly managed to revive the extinct dire wolf earlier this year ...
1d
Cyprus Mail on MSNBiotech pioneer offers guidance to Cyprus’ next generation of foundersDr Mary Lynne Hedley, a trailblazer in biotechnology and scientific entrepreneurship, recently visited Cyprus to inspire the next generation of life science innovators. A Senior Scientific Fellow at ...
Pharmaceutical companies have agreed to pay Hawaii $700 million to settle its lawsuit over the efficacy and safety of the blood thinne ...
While pharmaceutical companies typically have more mature cybersecurity programs ... "The smallest disruption in one part of ...
Direct-to-store model (delivering drugs directly to each retailer’s stores) of distributors are increasingly becoming more popular among retailers (represents 93% of sales in 2017, up from 74% in 2007 ...
A former critic of FDA and Pharma will now oversee the regulation of costly and complicated biologics like vaccines, gene therapies, and blood supply.
It was a good week for startups looking to raise big, as two companies raised rounds of well more than a half-billion dollars ...
Pfizer (NYSE:PFE) is one of the world’s largest pharmaceutical companies, but at $22.59 per share as of this writing, the ...
With one of the most densely concentrated life sciences hubs in Europe, the Netherlands sets its sights on becoming a global ...
Private biotechs in Switzerland raised CHF833 million (US$1.002 billion) in 2024, driving an overall increase in capital investment in the sector to $3 billion, up from $2.4 billion in 2023.
Biosimilars are gaining traction as competitors aim to capture market share from branded biologics such as Humira and ...
8d
MarketBeat on MSN3 Biotech Giants Gaining From U.S. Sales and Policy ShiftsIn today’s unpredictable global trade environment, with rising tariffs and tensions, investors are looking for stability.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results